Old Web
English
Sign In
Acemap
>
authorDetail
>
Jesse Huffman
Jesse Huffman
Washington University in St. Louis
Internal medicine
Medicine
Oncology
Adenocarcinoma
Irinotecan
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study.
2021
Investigational New Drugs
Katrina Pedersen
Patrick Grierson
Joel Picus
A. Craig Lockhart
Bruce J. Roth
Jingxia Liu
Ashley Morton
Emily Chan
Jesse Huffman
Chris Liang
Andrea Wang-Gillam
Benjamin R. Tan
Show All
Source
Cite
Save
Citations (1)
Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma.
2019
Journal of Clinical Oncology
Haeseong Park
Nikolaos A. Trikalinos
Aravind Sanjeevaiah
Katrina S. Pedersen
Nusayba Ali Bagegni
Andrew B. Nixon
Jesse Huffman
Benjamin R. Tan
Rama Suresh
Kian-Huat Lim
Manik Amin
Andrea Wang-Gillam
A. Craig Lockhart
Show All
Source
Cite
Save
Citations (0)
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma
2019
Journal of gastrointestinal oncology
Patrick Grierson
Andrea S. Teague
Rama Suresh
Kian-Huat Lim
Manik Amin
Katrina S. Pedersen
Benjamin R. Tan
Jesse Huffman
Nick Boice
Lingling Du
Jingxia Liu
A. Craig Lockhart
Andrea Wang-Gillam
Show All
Source
Cite
Save
Citations (1)
1